Absence of neurotoxicity of any grade in low-volume disease to-date – – On track for first Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL ...

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...

Werewolf Therapeutics, Inc. (the 'Company” or 'Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

To Bentley’s design centre, so new that the paint has barely dried, to experience something of a landmark: the conceptual ...

Samsung Electronics Co. introduced three new foldable smartphones in an effort to broaden mainstream appeal before Apple Inc.

Samsung opens pre-bookings for Galaxy Z 7 series. Sony WF-C710N earbuds launched. Amazfit Active 2 Square smartwatch. JBL ...

Q4 2025 Earnings Call Transcript July 8, 2025 Aehr Test Systems beats earnings expectations. Reported EPS is $-0.01, ...

Transaction Expected to be Accretive to Long-Term EPS Growth Rate; Texas Projected to Become Second Largest Utility Operation of H2O America by 20281 Company to Host Investor Webcast Today at 5:30 a.m ...

The main Department of Justice building, across from the National Archives in Washington, was the kind of brooding edifice ...

As Consumers Search for the Best Non-Prescription Eye Supplements in 2025, Visium Pro Highlights Clean Label Formulation, GMP ...

(73%) enrolled in the 180mg Q8W open label extension study achieved a complete response at 12 weeks Results from the 240mg Q8W and the 240mg followed by 180mg Q8W cohorts appear to be confounded by ...